Patients with non-evanescent prostate carcinoma displayed clear histological signs of PIN (69%), considerable cancer aggressiveness (50% patients with a Gleason score of 8 and above), increased levels of PSA (83.5 ± 252.2), and showed clinical and pathological features of cancer progression (TNM stages: IIA to IV). The gene discussed is KLK3; the disease is prostate carcinoma.